A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan

Journal of Infectious Diseases

Volumn 181, Issue 1, 2000, Pages 35-41

  Boschi Pinto, Cynthia ^a,b   Stuver, Sherri ^b   Okayama, Akihiko ^d   Trichopoulos, Dimitrios ^b   Orav, E John ^c   Tsubouchi, Hirohito ^d   Mueller, Nancy ^b  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; ENDEMIC DISEASE; FEMALE; HEPATITIS C; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; JAPAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HTLV-I INFECTIONS; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0033984271     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315177     Document Type: Article

References (58)

1. 1. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology 1997;26(Suppl 1):15S-20S.
2. 2. Seef LB. Natural history of hepatitis C. Hepatology 1997;26(Suppl 1):21S-8S.
3. 3. Purcell R. The hepatitis C virus: overview. Hepatology 1997;26(Suppl 1): 11S-4S.
4. 4. Alter HJ. To C or not to C: these are the questions. Blood 1995;85:1681-95.
5. 5. Degos F. Natural history of hepatitis C virus infection. Nephrol Dial Transplant 1996; 11(Suppl 4):16-8.
6. 6. Colombo M. The natural history of hepatitis C. Baillieres Clin Gastroenterol 1996;10:275-88.
7. 7. International Agency for Research on Cancer. Hepatitis viruses. IARC Monogr Eval Carcinog Risks Hum 1994;59:165-221.
8. 8. Okuda K. Hepatitis C virus and hepatocellular carcinoma. In: Okuda K, Tabor E, eds. Liver cancer. New York: Churchill Livingstone, 1997:39-50.
9. 9. Cacoub P, Fabiani FL, Musset L, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994;96:124-32.
10. 10. Ferri C, Baicchi U, La Civita L, et al. Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. Eur J Clin Invest 1993;23:851-5.
11. 11. Cacoub P, Lunel-Fabiani F, Du LTH. Polyarteritis nodosa and hepatitis C virus infection. Ann Intern Med 1992;116:605-6.
12. 12. Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialoadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-3.
13. 13. Jubert C, Pawlotsky JM, Pouget F, et al. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 1994;130:73-6.
14. 14. Nowicki MJ, Balistreri W. The hepatitis C virus: identification, epidemiology, and clinical controversies. J Pediatr Gastroenterol Nutr 1995;20:248-74.
15. 15. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328:465-70.
16. 16. Rollino C, Roccatello D, Giachino O, et al. Hepatitis C virus infection and membranous glomerulonephritis. Nephron 1991;59:319-20.
17. 17. Allison MED, Wreghitt T, Palmer CR, Alexander GJM. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994;21:1135-9.
18. 18. Gray H, Wreghitt T, Stratton IM, Alexander GJM. Turner RC, O'Rahilly S. High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests. Diabet Med 1995;12:244-9.
19. 19. Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;29:328-33.
20. 20. el-Zayadi AR, Selim OE, Hamdy H, et al. Association of chronic hepatitis C infection and diabetes mellitus. Trop Gastroenterol 1998;19:141-4
21. 21. Luppi M, Torelli G. The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: an overview. Haematologica 1996;81:265-81.
22. 22. Ferri C, Caracciolo F, Zignego AL, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994;88:392-4.
23. 23. Corell A, Morales JM, Mandrono A, et al. Immunosuppression induced by hepatitis C virus infection reduces acute renal-transplant rejection. Lancet 1995;346:1497-8.
24. 24. Bouffard P, Hayashi PH, Acevedo R, Levy N, Zeldis JB. Hepatitis C virus is detected in a monocyte/macrophage sub-population of peripheral blood mononuclear cells of infected patients. J Infect Dis 1992;166:1276-80.
25. 25. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 1984;81:2534-7.
26. 26. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2: 407-10.
27. 27. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986;1:1031-2.
28. 28. Yamaguchi K. Human T-lymphotropic virus type I in Japan. Lancet 1994; 343:213-6.
29. 29. Mueller NE, Blattner WA. Retroviruses: HTLV. In: Evans ES, Kaslow R, eds. Viral infections of humans: epidemiology and control. New York: Plenum Medical Book, 1994:785-814.
30. 30. Tachibana N, Okayama A, Ishizaki J, et al. Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan. Int J Cancer 1988;42: 829-31.
31. 31. Murai K, Nobuyoshi T, Shioiri S, et al. Suppression of delayed-type hypersensitivity to PPD and PHA in elderly HTLV-I carriers. J Acquir Immune Defic Syndr 1990;3:1006-9.
32. 32. Welles SL, Tachibana N, Okayama A, et al. Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status. Int J Cancer 1994;56:337-40.
33. 33. Koziel MJ, Dudley D, Afdhal N, et al. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 1993;67:7522-32.
34. 34. Zeldis JB, Jensen P. Hepatitis C virus pathogenicity: the corner pieces of the jigsaw puzzle are found. Gastroenterology 1994;106:1118-20.
35. 35. Lechmann M, Ihlenfeldt HG, Braunschweiger I, et al. T and B cell responses to different hepatitis C virus antigens in patients with chronic hepatitis and healthy seropositives. Hepatology 1996;24:790-5.
36. 36. Spengler U, Lechmann M, Irrgang B, Dumoulin FL, Sauerbruch T. Immune responses in hepatitis C virus infection. J Hepatol 1996;24(Suppl 2):20-5.
37. 37. Soto B, Sanchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997;26:1-5.
38. 38. Rockstroh JK, Spengler U, Sudhop T, et al. Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. Am J Gastroenterol 1996;91:2563-8.
39. 39. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
40. 40. Shioiri S, Tachibana N, Okayama A, et al. Analysis of anti-tax antibody of HTLV-I carriers in an endemic area in Japan. Int J Cancer 1993;53:1-4.
41. 41. Collet D. Modeling survival data in medical research. Texts in statistical science, London: Chapman & Hall, 1994.
42. 42. Rothman KJ. Modern epidemiology. Boston: Little, Brown, 1986.
43. 43. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3:452-6.
44. 44. Daskalakis C, Zavras AI. Assessing additive interactions in logistic regression models. Am J Epidemiol 1997;145:84.
45. 45. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-5.
46. 46. De Mitri MS, Poussin K, Baccarini P, et al. HCV-associated liver cancer without cirrhosis. Lancet 1995;345:413-5.
47. 47. Bosch FX. Global epidemiology of hepatocellular carcinoma. In: Okuda K, Tabor E, eds. Liver cancer. New York: Churchill Livingstone, 1997:13-28.
48. 48. Stuver SO, Okayama A, Tachibana N, Tsubouchi H, Mueller NE, Tabor E. HCV infection and liver cancer mortality in a Japanese population with HTLV-I. Int J Cancer 1996;67:35-7.
49. 49. Kamihira S, Momita S, Ikeda S, et al. Cohort study of hepatotropic virus and human T lymphotropic virus type-I infections in an area endemic for adult T cell leukemia. Jpn J Med 1991;30:492-7.
50. 50. Okayama A, Maruyama T, Tachibana N, et al. Increased prevalence of HTLV-I infection in patients with hepatocellular carcinoma associated with hepatitis C virus. Jpn J Cancer Res 1995;86:1-4.
51. 51. Eyster ME, Fried MW, DiBisceglie AM, et al. Increasing hepatitis C virus RNA levels in hemophiliacs with antibody to hepatitis C virus (HCV): relationship to human immunodeficiency virus (HIV) infection and liver disease. Blood 1994;84:1020-3.
52. 52. Guido M, Rugge M, Fattovich G, et al. Human immunodeficiency virus infection and hepatitis C pathology. Liver 1994;14:314-9.
53. 53. Soriano V, Bravo R, Mas A, Garcia-Samaniego J, Gutierrez M, Gonzalez-Lahoz J. Impact of immunosuppression caused by HIV infection on the replication of hepatitis C virus. Vox Sang 1995;69:259-60.
54. 54. Telfer PT, Brown D, Devereux H, Lee CA, DuSheiki GM. HCV RNA levels and HIV infection: evidence for a viral interaction in haemophilic patients. Br J Haematol 1994;88:397-9.
55. 55. Beld M, Penning M, Lukashov V, et al. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Virology 1998;244:504-12.
56. 56. Hisada M, Shima T, Okayama A, Mueller N, Tsubouchi H, Stuver S. Suppression of skin reactivity to purified protein derivative by hepatitis C virus among HTLV-I carriers in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:421-5.
57. 57. Nasrallah SM, Wills CE, Galambos JT. Hepatic morphology in obesity. Dig Dis Sci 1981;26:325-7.
58. 58. Laskus T, Radkowski M, Wang LF, et al. Search for hepatitis C virus extrahepalic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology 1998;28:1398-401.